biocytogen

Exhibitor

Biocytogen is a global biotech company advancing antibody drug development through innovative technologies. Leveraging gene-editing expertise, it pioneered drug target knock-in humanized models and offers 3,000+ models via BioMiceā„¢, along with in vivo, ex vivo, and in vitro pharmacology and custom gene-editing services.
Biocytogen drives fully human monoclonal antibody discovery and offers 400,000+ antibody sequences targeting 1,000 proteins through its RenBiologicsā„¢ sub-brand for global partnerships.



website

Get involved at Festival of Biologics Basel 2025

 

 

TO SPONSOR


Derek Cavanagh

[email protected]

 

Jack Bebb
[email protected]

 

TO SPEAK


Jack Beard
[email protected]

 

MARKETING & PRESS


Ollie McDaid

[email protected]

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.